Public SEC Form D records
Biotech Series A Form D filings - September 2026
This page lists the 31 matching Form D filings FormDFlow has indexed and tagged from public SEC EDGAR records for Biotech-tagged issuers at a FormDFlow-inferred Series A stage in September 2026 - a filtered subset, not every matching Form D filed, and not a ranked, curated, or recommended selection. FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.
- Filings
- 31
- Issuers
- 31
- Combined disclosed
- $194.4M
Directory links
Filing records
31 crawlable filing links in this facet.
- Vetmab Biosciences, Inc.September 29, 2026 / Reg D 506(b) / CA$11.9M
- Evia Bio, Inc.September 28, 2026 / Reg D 506(b) / MN$5.5M
- Pictura Bio US, Inc.September 28, 2026 / Reg D 506(b)$15.0M
- Dignify Therapeutics, LLCSeptember 25, 2026 / Reg D 506(b) / NC$3.0M
- Verinomics, Inc.September 25, 2026 / Reg D 506(b) / CT$12.8M
- EyeMacular Regeneration, Inc.September 25, 2026 / Reg D 506(b) / MN$6.0M
- Way Biosolutions, Inc.September 25, 2026 / Reg D 506(b) / MA$2.0M
- Biophytis SASeptember 23, 2026 / Reg D 506(b)$2.6M
- Hera Biotech, Inc.September 23, 2026 / Reg D 506(b) / TX$5.0M
- Uvantis Therapeutics, Inc.September 23, 2026 / Reg D 506(b) / MD$5.0M
- Navion Neurosciences Inc.September 22, 2026 / Reg D 506(b) / VA$5.1M
- Pierrepont Therapeutics, Inc.September 22, 2026 / Reg D 506(b) / NY$5.9M
- Bioinsights, Inc.September 22, 2026 / Reg D 506(b) / FL$7.9M
- iQure Pharma Inc.September 21, 2026 / Reg D 506(b) / NJ$4.0M
- Oncobiomix Inc.September 16, 2026 / Reg D 506(b) / TX$2.5M
- Hexamer Therapeutics, IncSeptember 15, 2026 / Reg D 506(b) / WA$2.5M
- Harvard Apparatus Regenerative Technology, Inc.September 14, 2026 / Reg D 506(b) / MA$3.0M
- Tempo Therapeutics, Inc.September 11, 2026 / Reg D 506(b) / CA$14.5M
- Savannah Therapeutics, IncSeptember 11, 2026 / Reg D 506(b) / MD$6.0M
- Polyrizon Ltd.September 10, 2026 / Reg D 506(b)$4.0M
- Can-Fite BioPharma Ltd.September 10, 2026 / Reg D 506(b)$8.3M
- Praeventix, Inc.September 10, 2026 / Reg D 506(b) / PA$5.6M
- BioLineRx Ltd.September 9, 2026 / Reg D 506(b)$3.8M
- Animal Biosciences, Inc.September 9, 2026 / Reg D 506(b) / MA$2.6M
- SAFETYSPECT INCSeptember 8, 2026 / Reg D 506(c) / ND$10.0M
- Klothea Bio, Inc.September 8, 2026 / Reg D 506(b) / FL$10.4M
- Pluri Inc.September 4, 2026 / Reg D 506(b)$3.7M
- Sensible Biotechnologies, Inc.September 2, 2026 / Reg D 506(b)$15.0M
- Aclarity Genomics, Inc.September 2, 2026 / Reg D 506(b) / NC$4.6M
- Kaida BioPharma Inc.September 1, 2026 / Reg D 506(b) / FL$4.1M
- Voxcell BioInnovation Inc.September 1, 2026 / Reg D 506(b)$2.2M